Otto Dawn Parsell
EVP, Clinical Development at Tricida, Inc.
- Sold, on record
- $2.8M
- Dollars the filings state
- Form 4 sales
- 16
- Latest May 8, 2020
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Tricida, Inc.EVP, Clinical Development
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Tricida, Inc.UnusualOct 28, 2019 2019
Sold 5,300 shares at $37.25 ($197k)
Otto Dawn Parsell, Sr VP, Clinical Development
Sold 100% of holdings ($197k position)0 shares left1.1x usual sizeFiling
- 2 Form 4 sale Tricida, Inc.UnusualNov 26, 2019 +29 days
Sold 5,746 shares at $39.60 ($228k)
Otto Dawn Parsell, Sr VP, Clinical Development
Sold 100% of holdings ($228k position)0 shares left1.1x usual sizeFiling
- 3 Form 4 sale Tricida, Inc.UnusualJan 2, 2020 +37 days
Sold 4,250 shares at $37.04 ($157k)
Otto Dawn Parsell, Sr VP, Clinical Development
Sold 94.3% of holdings ($167k position)255 shares left0.8x usual sizeFiling
- 4 Form 4 sale Tricida, Inc.UnusualFeb 3, 2020 +32 days
Sold 4,250 shares at $36.86 ($157k)
Otto Dawn Parsell, Sr VP, Clinical Development
Sold 94.3% of holdings ($166k position)255 shares left0.9x usual sizeFiling
- 5 Form 4 sale Tricida, Inc.UnusualMar 2, 2020 +28 days
Sold 4,250 shares at $31.84 ($135k)
Otto Dawn Parsell, EVP, Clinical Development
Sold 94.3% of holdings ($143k position)255 shares left0.9x usual sizeFiling
- 6 Form 4 sale Tricida, Inc.UnusualApr 29, 2020 +58 days
Sold 4,250 shares at $31.39 ($133k)
Otto Dawn Parsell, EVP, Clinical Development
Sold 94.3% of holdings ($141k position)255 shares left0.9x usual sizeFiling
- 7 Form 4 sale Tricida, Inc.UnusualMay 5, 2020 +6 days
Sold 1,250 shares at $30.14 ($38k)
Otto Dawn Parsell, EVP, Clinical Development
Sold 83.1% of holdings ($45k position)255 shares left0.3x usual sizeFiling
- 8 Form 4 sale Tricida, Inc.UnusualMay 8, 2020 +3 days
Sold 3,000 shares at $31.98 ($96k)
Otto Dawn Parsell, EVP, Clinical Development
Sold 92.2% of holdings ($104k position)255 shares left0.7x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (16)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| May 8, 2020 | May 12, 2020 | Tricida, Inc. | EVP, Clinical Development | Form 4 sale | 3,000 | $96k | 92.2% | Unusual | SEC |
| May 5, 2020 | May 7, 2020 | Tricida, Inc. | EVP, Clinical Development | Form 4 sale | 1,250 | $38k | 83.1% | Unusual | SEC |
| Apr 29, 2020 | Apr 30, 2020 | Tricida, Inc. | EVP, Clinical Development | Form 4 sale | 4,250 | $133k | 94.3% | Unusual | SEC |
| Mar 2, 2020 | Mar 4, 2020 | Tricida, Inc. | EVP, Clinical Development | Form 4 sale | 4,250 | $135k | 94.3% | Unusual | SEC |
| Feb 3, 2020 | Feb 5, 2020 | Tricida, Inc. | Sr VP, Clinical Development | Form 4 sale | 4,250 | $157k | 94.3% | Unusual | SEC |
| Jan 2, 2020 | Jan 6, 2020 | Tricida, Inc. | Sr VP, Clinical Development | Form 4 sale | 4,250 | $157k | 94.3% | Unusual | SEC |
| Nov 26, 2019 | Nov 27, 2019 | Tricida, Inc. | Sr VP, Clinical Development | Form 4 sale | 5,746 | $228k | 100.0% | Unusual | SEC |
| Oct 28, 2019 | Oct 30, 2019 | Tricida, Inc. | Sr VP, Clinical Development | Form 4 sale | 5,300 | $197k | 100.0% | Unusual | SEC |
| Sep 25, 2019 | Sep 27, 2019 | Tricida, Inc. | Sr VP, Clinical Development | Form 4 sale | 5,300 | $172k | 100.0% | Unusual | SEC |
| Aug 28, 2019 | Aug 30, 2019 | Tricida, Inc. | Sr VP, Clinical Development | Form 4 sale | 5,000 | $168k | 100.0% | Unusual | SEC |
| Jul 29, 2019 | Jul 30, 2019 | Tricida, Inc. | Sr VP, Clinical Development | Form 4 sale | 5,000 | $156k | 100.0% | Unusual | SEC |
| Jul 3, 2019 | Jul 5, 2019 | Tricida, Inc. | Sr VP, Clinical Development | Form 4 sale | 15,407 | $571k | 100.0% | Unusual | SEC |
| Mar 28, 2019 | Mar 29, 2019 | Tricida, Inc. | Sr VP, Clinical Development | Form 4 sale | 15,500 | $476k | 100.0% | Unusual | SEC |
| Mar 18, 2019 | Mar 19, 2019 | Tricida, Inc. | Sr VP, Clinical Development | Form 4 sale | 2,500 | $63k | 100.0% | Unusual | SEC |
| Mar 13, 2019 | Mar 15, 2019 | Tricida, Inc. | Sr VP, Clinical Development | Form 4 sale | 2,000 | $50k | 100.0% | Unusual | SEC |
| Jan 7, 2019 | Jan 8, 2019 | Tricida, Inc. | Sr VP, Clinical Development | Form 4 sale | 665 | $15k | 100.0% | Unusual | SEC |